The resilience of P. vivax to malaria elimination efforts is due to its ability to form dormant liver stages
(hypnozoites) that reactivate weeks to months after the initial infection causing recurrent episodes of malaria
(relapses) and ongoing parasite transmission. Relapses account for 60-90% of recurrent infections and clinical
cases of P. vivax malaria, and therefore have a significant effect on morbidity at the individual level.
